Author/Authors :
Myint Aung, Sammy San Institute for Heart and Vascular Health - Renown Regional Medical Center, NV, USA , Latt, Htun Department of Internal Medicine - School of Medicine - University of Nevada-Reno, NV, USA , Kyaw, Kyaw Institute for Heart and Vascular Health - Renown Regional Medical Center, NV, USA , Roongsritong, Chanwit Institute for Heart and Vascular Health - Renown Regional Medical Center, NV, USA
Abstract :
Coronary interventions are the mainstay of treatment for stenotic coronary vascular lesions. New stent designs are constantly being
evaluated to improve stent performances and clinical outcomes. Coronary stent fracture is uncommon; however, it is associated
with potential major consequences including acute coronary syndrome and the need for repeated target vessel revascularization
due to in-stent restenosis or stent thrombosis. We report a case of a 66-year-old man with an extensive cardiac disease history,
who presented with intractable angina and was found to have a fracture of a current generation, platinum chromium
everolimus-eluting stent (Synergy, Boston Scientific Inc.).
